Michael Sandhu, MD (@michaelsandhumd) 's Twitter Profile
Michael Sandhu, MD

@michaelsandhumd

Hematology/Oncology Fellow @MontefioreNYC @EinsteinMed | Former IM/Chief @UpstateNews, @WesternU 🇨🇦 | Interests: #MedEd, Heme Malignancies | #LeafsForever 🏒

ID: 1638961587925942272

linkhttps://www.researchgate.net/profile/Michael-Sandhu calendar_today23-03-2023 17:51:14

119 Tweet

759 Followers

550 Following

Chris Moriates, MD (@chrismoriates) 's Twitter Profile Photo

The coffee was mediocre at best, but for this man it was worth risking his life for. My essay, "The Coffee Contract," in Journal of Hospital Medicine about remembering what really matters in the hospital: …mpublications.onlinelibrary.wiley.com/doi/10.1002/jh…

The coffee was mediocre at best, but for this man it was worth risking his life for.

My essay, "The Coffee Contract," in <a href="/JHospMedicine/">Journal of Hospital Medicine</a> about remembering what really matters in the hospital: 

…mpublications.onlinelibrary.wiley.com/doi/10.1002/jh…
Aaron Goodman - “Papa Heme” (@aarongoodman33) 's Twitter Profile Photo

Respiratory failure in patients with hematologic malignancies This is really an amazing review in Blood Journal on respiratory failure in patients with hematologic malignancies. A must read for ICU docs, pulm, ID, and hematologists. Gabriel Wardi tinyurl.com/y4ws6pt7

Respiratory failure in patients with hematologic malignancies

This is really an amazing review in <a href="/BloodJournal/">Blood Journal</a> on respiratory failure in patients with hematologic malignancies.

A must read for ICU docs, pulm, ID, and hematologists.  
<a href="/WardiGabriel/">Gabriel Wardi</a> 

tinyurl.com/y4ws6pt7
H.O.M.E (@hemeoncfellow) 's Twitter Profile Photo

Congratulations to our very own Michael Sandhu, MD, HOME Mentor/ incoming Heme-Onc fellow Montefiore Health System Albert Einstein College of Medicine - Official presenting on #Communication Gaps at the #SHMConverge24 & meeting up with our H.O.M.E trainees. 😊 #Medtwitter #Mentorship #Communication #HospitalMedicine

Congratulations to our very own <a href="/MichaelSandhuMD/">Michael Sandhu, MD</a>, HOME Mentor/ incoming Heme-Onc fellow <a href="/MontefioreNYC/">Montefiore Health System</a> <a href="/EinsteinMed/">Albert Einstein College of Medicine - Official</a>  presenting on #Communication Gaps at the #SHMConverge24 &amp; meeting up with our <a href="/hemeoncfellow/">H.O.M.E</a> trainees. 😊
#Medtwitter
#Mentorship
#Communication
#HospitalMedicine
Aaron Goodman - “Papa Heme” (@aarongoodman33) 's Twitter Profile Photo

What an exciting time to be a hematologist/BMT/cell therapist doc! All 3 of 4 original articles with new exciting therapies in our field. Med students make sure you rotate on BMT so you get a taste of the magic and science fiction that is our job.

What an exciting time to be a hematologist/BMT/cell therapist doc!

All 3 of 4 original articles with new exciting therapies in our field.   

Med students make sure you rotate on BMT so you get a taste of the magic and science fiction that is our job.
Rami Manochakian MD, FASCO 🇺🇸🇸🇾CancerEducation (@rmanochakian) 's Twitter Profile Photo

🚨🔥1/4 OncoAlert Hot off the press. Excited to share this just published paper at 2024 ASCO #EducationalBook #ASCOEdBook “Launching an International Community of Practice in #HematologyOncology #MedicalEducation #ASCOMedEdCoP” ASCO OncMedEdCoP 👇🏼 ascopubs.org/doi/10.1200/ED…

🚨🔥1/4 <a href="/OncoAlert/">OncoAlert</a> Hot off the press.

Excited to share this just published paper at 2024 <a href="/ASCO/">ASCO</a> #EducationalBook #ASCOEdBook 

“Launching an International Community of Practice in #HematologyOncology #MedicalEducation #ASCOMedEdCoP”

<a href="/OncMedEdCoP/">ASCO OncMedEdCoP</a>
👇🏼
ascopubs.org/doi/10.1200/ED…
Kaitlyn McSurdy (@kaitlyn_mcsurdy) 's Twitter Profile Photo

being a #chiefresident is truly the weirdest job in the world, but with just over one week left, I’ve been really reflecting on what a growth experience this has been both personally and professionally. here are 12 things I learned (other than how to be a much better educator):

Balazs Halmos (@drstevemartin) 's Twitter Profile Photo

What an amazing night w our extended Montefiore Health System Albert Einstein College of Medicine - Official family incl a Giant of Onc ranging from ‘86 (yes- The Sparanos!) to just abt starting Michael Sandhu, MD And the icing on the cake -or gulab jamun 🇮🇳was seeing the amazing success of 4 of our prior thoracic mentees!

deevyaparekh (@deevyaparekh) 's Twitter Profile Photo

💊Does 5-FU dose adjustment for DPYD mutation affect toxicity 🧬118 had no DPYD mutation, 44 heterozygous. 💉5-FU dose adjusted per CPIC guidelines ✅No statistically significant difference in toxicity; CPIC adjustment appropriate for tolerability #ASCO24 SUNY Upstate IM Residency

💊Does 5-FU dose adjustment for DPYD mutation affect toxicity

🧬118 had no DPYD mutation, 44 heterozygous.

💉5-FU dose adjusted per CPIC guidelines 

✅No statistically significant difference in toxicity; CPIC adjustment appropriate for tolerability 

#ASCO24 <a href="/UpstateIM_Res/">SUNY Upstate IM Residency</a>
Balazs Halmos (@drstevemartin) 's Twitter Profile Photo

Excellent work by Angelica D'Aiello, MD (let me also introduce her as incoming Montefiore Health System faculty!), Shayan Nazari Caris Life Sciences, Hyein Jeon, MD Haiying Cheng on a mol analysis of alternate checkpoints in NSCLC! This project is Angelica’s baby-but as she is also a new mom-a close 2nd one👶

Excellent work by <a href="/DAielloMD/">Angelica D'Aiello, MD</a> (let me also introduce her as incoming <a href="/MontefioreNYC/">Montefiore Health System</a> faculty!), Shayan Nazari <a href="/carisls/">Caris Life Sciences</a>, <a href="/HyeinJeon_MD/">Hyein Jeon, MD</a>   <a href="/HaiyingCheng/">Haiying Cheng</a> on a mol analysis of alternate checkpoints in NSCLC!
This project is Angelica’s baby-but as she is also a new mom-a close 2nd one👶
Jorge Avila (@jorgeeavila) 's Twitter Profile Photo

Here are my 2 cents on fellowship application. Feel free to take a look and hopefully this can guide those who are applying or are planning to apply to #HemeOnc

Dr. Antonio Calles 🫁🚭 (@tony_calles) 's Twitter Profile Photo

💥 The end of Pembro reign? Phase 3 Study of Ivonescimab (AK112) vs. Pembrolizumab as First-line Treatment for PD-L1-positive Advanced NSCLC: HARMONi-2 #WCLC24 #LCSM

💥 The end of Pembro reign? 
Phase 3 Study of Ivonescimab (AK112) vs. Pembrolizumab as First-line Treatment for PD-L1-positive Advanced NSCLC: HARMONi-2 #WCLC24 #LCSM